Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that
causes continuous mucosal inflammation extending from the rectum to the more proximal …

1.2. Definitions Ulcerative colitis [UC] is a chronic inflammatory condition that causes
continuous mucosal inflammation of the colon, usually without granulomas on biopsy. It …

Background & Aims The comparative efficacy and safety of infliximab and azathioprine
therapy alone or in combination for ulcerative colitis (UC) have not been evaluated …

Ulcerative colitis is a lifelong disease arising from an interaction between genetic and
environmental factors, observed predominantly in the developed countries of the world. The …

Background Ulcerative colitis is a chronic inflammatory disease of the colon for which
current treatments are not universally effective. One additional treatment may be tofacitinib …

The management of inflammatory bowel disease represents a key component of clinical
practice for members of the British Society of Gastroenterology (BSG). There has been …

Methods: These guidelines are a joint effort of the European Crohn's and Colitis
Organization (ECCO) and the European Society of Paediatric Gastroenterology, Hepatology …

Background & Aims Guidelines for the management of venous thromboembolism (VTE) from
the American College of Chest Physicians do not address patients with inflammatory bowel …

Background and aims: Although inflammatory bowel diseases (IBD) significantly impact the
patient's quality of life, no European-level data exists on patients' perspectives. The primary …

Background Ciclosporin and infliximab are potential rescue treatments to avoid colectomy in
patients with acute severe ulcerative colitis refractory to intravenous corticosteroids. We …